Pabinafusp alfa Completed Phase 2 Trials for Mucopolysaccharidosis Type II (MPS II) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03359213A Study of JR-141 in Patients With Mucopolysaccharidosis II